Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Quarter and Full Year Highlighted by Further Progress in Advancing Beloranib Clinical Development Program Company to Report Data from Ongoing Clinical Trials in Late 2015/Early 2016 Enters 2015...
-
BOSTON, March 12, 2015 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity and...
-
Poster Number LBS-095 SAN DIEGO, March 7, 2015 (GLOBE NEWSWIRE) -- Zafgen, Inc., a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by...
-
BOSTON, Feb. 27, 2015 (GLOBE NEWSWIRE) -- Zafgen, Inc., a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity and complex metabolic...
-
BOSTON, Feb. 26, 2015 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity, today...
-
BOSTON, Feb. 18, 2015 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity, today...
-
BOSTON, Feb. 5, 2015 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity, today...
-
BOSTON, Jan. 28, 2015 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN) today announced the closing of its underwritten public offering of 3,942,200 shares of its common stock at a price of $35.00 per...
-
BOSTON, Jan. 22, 2015 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN) today announced the pricing of its underwritten public offering of 3,942,200 shares of its common stock at a price of $35.00 per...
-
BOSTON, Jan. 20, 2015 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN) today announced that it has commenced an underwritten public offering of 2,840,909 shares of its common stock. In addition, Zafgen...